FourThought Financial Partners, LLC

Position in JNJ — Johnson & Johnson

CIK 1956790 VENICE, FL

Position in JNJ

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,801,168

+$127,724 QoQ

Shares Held

14,967

-0.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.35%

of 13F equity value

Holder Rank

#1,817

of 4,676 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FourThought Financial Partners, LLC holds $48,924,367 across 10 Drug Manufacturers - General names. JNJ ranks #6 (7.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	80,917	$15,343,481
2	AMGN	Amgen Inc	32,361	$11,718,565
3	LLY	ELI LILLY & Co	5,899	$7,075,438
4	NVO	Novo Nordisk A S	102,109	$4,895,105
5	ABBV	AbbVie Inc.	17,032	$4,285,932
6	JNJ	Johnson & Johnson This page	14,967	$3,801,168
7	MRK	Merck & Co., Inc.	4,550	$584,675
8	GILD	Gilead Sciences, Inc.	3,418	$431,830

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,801,168	14,967	-0.4%	Shares	Sole	2026-08-12
2026-03-31	$3,673,444	15,028	-2.4%	Shares	Sole	2026-05-07
2025-12-31	$3,187,857	15,404	+0.7%	Shares	Sole	2026-02-06
2025-09-30	$2,836,740	15,299	-1.5%	Shares	Sole	2025-11-13
2025-06-30	$2,372,665	15,533	-6.5%	Shares	Sole	2025-08-12
2025-03-31	$2,755,929	16,618	-62.9%	Shares	Sole	2025-05-07
2024-12-31	$6,477,529	44,790	-11.2%	Shares	Sole	2025-02-04
2024-09-30	$8,176,089	50,451	+0.7%	Shares	Sole	2024-11-13
2024-06-30	$7,322,762	50,101	+1.9%	Shares	Sole	2024-08-13
2024-03-31	$7,775,987	49,156	+4.1%	Shares	Sole	2024-05-14
2023-12-31	$7,401,262	47,220	+0.2%	Shares	Sole	2024-02-13
2023-09-30	$7,342,522	47,143	-12.4%	Shares	Sole	2023-11-13
2023-06-30	$8,910,603	53,834	-21.1%	Shares	Sole	2023-08-11
2023-03-31	$10,573,170	68,214	-1.6%	Shares	Sole	2023-05-04
2022-12-31	$12,239,725	69,288	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.